Skip to content

CM Life Sciences closes $442.8M IPO

September 4, 2020

CM Life Sciences (CMLFclosed its initial public offering of 44.3M units at $10/unit; includes 5.78M units issued post underwriters exercising option in full.

Units listed on Nasdaq, commenced trading on September 2.

Each unit consists of one share of Class A common stock and one-third of one redeemable warrant; each whole warrant exercisable to purchase one share of Class A common stock at $11.50/share.

The company is formed for the purpose of effecting a business combination.

Intends to focus its search for business combination targets in life sciences industry segments, often fragmented, – life sciences tools, synthetic biology and diagnostics.

https://seekingalpha.com/news/3611830-cm-life-sciences-closes-442_8m-ipo

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: